Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06657794 · ClinicalTrials.gov registry record · NA
Physician Modified Endovascular Grafts for the Treatment of Juxtarenal Aortic Aneurysms
A NA study of Juxtarenal Aortic Aneurysm and Aortic Rupture, sponsored by The Cleveland Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT06657794: Recruiting NA study of Juxtarenal Aortic Aneurysm and Aortic Rupture, sponsored by The Cleveland Clinic.
NCT06657794 is a NA study of Juxtarenal Aortic Aneurysm and Aortic Rupture that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 15 participants, below the 151-participant average among 4 other Juxtarenal Aortic Aneurysm trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06657794, a NA study of Juxtarenal Aortic Aneurysm and Aortic Rupture, is actively recruiting participants, sponsored by The Cleveland Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of the clinical investigation "Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysms" is to assess the use of the Physician-Modified Endovascular Grafts to repair juxtarenal aneurysms in high-risk subjects considered to be unsuitable candidates for open surgical repair, have limited or no other options for treatment, and having appropriate anatomy. The primary intent of the study is to assess safety and preliminary effectiveness of the device: * acutely (i.e., treatment success and technical success); * at 30 days (i.e., the rate of major adverse events (MAE)); and * at 6 months, 12 months and annually to 5 years (i.e., the proportion of treatment group subjects that achieve and maintain treatment success).
Primary Outcome
The proportion of patients that experience a rate of Major Adverse Events
Conditions Studied
Interventions
- DEVICE Implantation of Physician-Modified Terumo Aortic TREO abdominal stent graft system
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-02-17 |
| Est. Completion | 2030-12-31 |
| Phase | NA |
What NCT06657794 shows while recruiting
NCT06657794 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 151-participant average among 4 other Juxtarenal Aortic Aneurysm trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Juxtarenal Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Implantation of Physician-Modified Terumo Aortic TREO abdominal stent graft system is the first listed.
NCT06657794 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06657794 about?
NCT06657794 is a clinical study titled "Physician Modified Endovascular Grafts for the Treatment of Juxtarenal Aortic Aneurysms". The primary objective of the clinical investigation "Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysms" is to assess the use of the Physician-Modified Endovascular Grafts to repair juxtarenal aneurysms in high-risk subjects cons...
What is the current status of trial NCT06657794?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2025-02-17. Estimated completion is 2030-12-31.
What conditions does trial NCT06657794 study?
This clinical trial studies the following conditions: Juxtarenal Aortic Aneurysm, Aortic Rupture.
What interventions are being tested in trial NCT06657794?
The interventions under investigation include: Implantation of Physician-Modified Terumo Aortic TREO abdominal stent graft system (DEVICE).
Who is sponsoring clinical trial NCT06657794?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06657794 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Juxtarenal Aortic Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
RECRUITING · NA
-
Clinical Outcomes and Major Adverse Events in Patients Treated With Physician-Modified Fenestrated and Branched Stent Grafts
RECRUITING · NA
-
Physician Modified Endograft For Complex Aortic Aneurysm Repair
RECRUITING · NA
-
Zenith® Fenestrated+ Clinical Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI